Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1023 of 5804
-
Zapping nerves to tame stubborn high blood pressure and diabetes?
Disease control Not yet recruitingTo assess the safety and effectiveness of renal artery denervation with subsequent splanchnic nerves denervation via catheter-based radiofrequency ablation in improving blood pressure and glycemic control in patients with resistant hypertension and type 2 diabetes.
Phase: NA • Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could more caffeine help tiniest babies breathe easier?
Disease control Not yet recruitingThe goal of this clinical trial is to determine whether a higher dose of caffeine citrate can improve breathing and reduce health complications in extremely premature infants, specifically those born before 28 weeks of pregnancy, known as ELGAN infants. These babies often struggl…
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a Plant-Based pill help HIV patients quit smoking and drinking?
Disease control Not yet recruitingPeople with HIV (PWH) smoke tobacco cigarettes and drink alcohol at higher rates than the general population, both in the US and internationally, including low- and middle-income countries. Now that effective antiretroviral therapy is available throughout most of the world, PWH a…
Phase: PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New infrared scanner aims to spot breast cancer before tumors form
Diagnosis Not yet recruitingWhen we talk about early identification, we are talking about an ALREADY EXISTING INJURY, triggering a change in the patient's quality of life and a projection of future costs for the health system. INNOVATIVE ASPECT: While screening mammography identifies an existing lesion, VT…
Phase: NA • Sponsor: Galzu Institute of Research, Teaching, Science and Applied Technology • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New study tests if tumor genes and organoids can outsmart pancreatic cancer
Knowledge-focused Not yet recruitingPancreatic cancer is burdened by a survival of barely 10% at 5 years. About 80% of new cases do not qualify for surgery due to either locally-advanced or metastatic disease. In patients with good performance status (PS), palliative first-line treatments mainly consist of combinat…
Sponsor: Prof. Dr. med. Dres. h.c. Jan Schmidt, MME • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New combo attack on hard-to-treat myeloma enters human testing
Disease control Not yet recruitingThis study is a prospective, single-arm, multicenter trial designed to evaluate the hematologic response rate and safety of BCMA/CD3 bispecific antibody bridging therapy prior to CAR-T cell infusion in patients with relapsed/refractory multiple myeloma (RRMM).
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Immune cells armed with cancer-seeking antibodies tested in advanced cancers
Disease control Recruiting nowThe purpose of this study is to understand the safety and estimate the efficacy of anti-CD3 x anti-HER2 bispecific antibody (HER2Bi) armed fresh peripheral blood mononuclear cells (HER2 FPBMC) for patients with metastatic breast or prostate cancer. Participants receive 5 weekly d…
Phase: PHASE1, PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Smartphone app aims to stop pregnancy diabetes before it starts
Prevention Not yet recruitingThis study aims to develop and evaluate an early risk identification and digital health intervention strategy for gestational diabetes mellitus (GDM) among pregnant women in China. Gestational diabetes mellitus is a common pregnancy complication associated with adverse maternal a…
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Could a zappy headband cure lazy eye? new trial hopes so
Symptom relief Not yet recruitingThe goal of this randomized, double-blind clinical trial is to determine whether transcranial direct current stimulation (tDCS) can effectively and safely improve vision in children aged 4-14 years with strabismic or anisometropic amblyopia that has not responded to conventional …
Phase: NA • Sponsor: Universidad de Murcia • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
CBD may cut opioid need in advanced prostate cancer
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate the effects of cannabidiol in patients with end-stage metastatic castration-resistant prostate cancer (mCRPC). The primary objective is to determine whether cannabidiol (CBD) treatment can reduce the need for opioids in patients wit…
Phase: PHASE2 • Sponsor: Regionshospital Nordjylland • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
AI and footprints: a new way to detect scoliosis?
Diagnosis Not yet recruitingThis study aims to evaluate whether plantar pressure data collected during standing and walking can be used with machine learning to support early detection of scoliosis in young people. Patients with scoliosis and healthy volunteers aged 10-18 will undergo a short assessment usi…
Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New Dual-Action shot could tame PCOS symptoms
Disease control Recruiting nowPolycystic ovary syndrome (PCOS) is the most common reproductive endocrine and metabolic disorder among women of reproductive age. It is characterized by oligo-ovulation or anovulation, clinical and/or biochemical hyperandrogenism, and polycystic ovarian morphology. In addition, …
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill takes on tough blood cancers in first human trial
Disease control Not yet recruitingThis is a first-in-human, multicenter, open-label, single-arm Phase I study of FXS0683 in participants with relapsed or refractory hematologic malignancies to evaluate safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity, and to determine the maximum to…
Phase: PHASE1 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New chemo cocktail aims to slow advanced colon cancer
Disease control Not yet recruitingThis is a prospective, multicenter, randomized controlled, phase II study. It is expected to enroll 229 patients and aims to evaluate the efficacy and safety of FOLFOX8 versus mFOLFOX6 combined with bevacizumab or cetuximab as first-line treatment for unresectable metastatic colo…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can pressurized oxygen boost stroke recovery?
Disease control Recruiting nowThe purpose of this RCT trial is to evaluate whether the sequential hyperbaric oxygen therapy can improve the 90-day functional outcome in patients with acute large vessel occlusion ischemic stroke after endovascular treatment.
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Sound waves could help chemo reach breast tumors
Disease control Recruiting nowThis study aimed to evaluate the feasibility and safety, and to observe early efficacy signals of the focused ultrasound mediated drug delivery system combined with SonoVue® in patients with HER2-positive breast cancer receiving neoadjuvant therapy by comparing its pathological c…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Gut germs for brain gains: probiotic trial aims to boost preterm baby development
Disease control Not yet recruitingThe purpose of this randomized controlled trial is to evaluate the effect of daily supplementation with a probiotic mixture on the neurodevelopmental outcomes of preterm infants with a history of neonatal antibiotic exposure. The intervention lasts for 6 months. The study hypothe…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New shot plus light therapy aims to restore skin color in vitiligo
Disease control Not yet recruitingThis is a randomized, double-blind, placebo-controlled Phase Ib/II clinical trial of multiple subcutaneous injections of GR2301 in combination with phototherapy to evaluate the tolerability, safety, pharmacokinetics, and preliminary efficacy in trial participants with vitiligo. T…
Phase: PHASE1, PHASE2 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Gum disease gel could save your teeth
Disease control Not yet recruitingChronic periodontitis is one of the most prevalent inflammatory diseases affecting the tooth-supporting structures and is characterized by progressive clinical attachment loss and alveolar bone resorption resulting from a complex interaction between pathogenic microorganisms and …
Phase: PHASE4 • Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Off-the-Shelf CAR t cells take on tough blood cancers
Disease control Recruiting nowThe purpose of this study is to assess the feasibility, safety and efficacy of universal CAR T cell therapy against CD19-positive hematological malignancies using a novel CD19-specific CAR T cell product, 4SCAR19U T cells. The study also aims to learn more about the function of t…
Phase: PHASE1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC